The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effects
Open Access
- 29 July 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 17 (1), 1-12
- https://doi.org/10.1186/s12916-019-1379-5
Abstract
Colorectal cancer is the third most common cancer in the world. In this study, we assessed the long-term survival characteristics and prognostic associations and potential time-varying effects of clinico-demographic variables and two molecular markers (microsatellite instability (MSI) and BRAF Val600Glu mutation) in a population-based patient cohort followed up to ~ 19 years. The patient cohort included 738 incident cases diagnosed between 1999 and 2003. Cox models were used to analyze the association between the variables and a set of survival outcome measures (overall survival (OS), disease-specific survival (DSS), recurrence-free survival (RFS), metastasis-free survival (MFS), recurrence/metastasis-free survival (RMFS), and event-free survival (EFS)). Cox proportional hazard (PH) assumption was tested for all variables, and Cox models with time-varying effects were used if any departure from the PH assumption was detected. During the follow-up, ~ 61% patients died from any cause, ~ 26% died from colorectal cancer, and ~ 10% and ~ 20% experienced recurrences and distant metastases, respectively. Stage IV disease and post-diagnostic recurrence or metastasis were strongly linked to risk of death from colorectal cancer. If a patient had survived the first 6 years without any disease-related event (i.e., recurrence, metastasis, or death from colorectal cancer), their risks became very minimal after this time period. Distinct sets of markers were associated with different outcome measures. In some cases, the effects by variables were constant throughout the follow-up. For example, MSI-high tumor phenotype and older age at diagnosis predicted longer MFS times consistently over the follow-up. However, in some other cases, the effects of the variables varied with time. For example, adjuvant radiotherapy treatment was associated with increased risk of metastasis in patients who received this treatment after 5.5 years post-diagnosis, but not before that. This study describes the long-term survival characteristics of a prospective cohort of colorectal cancer patients, relationships between baseline variables and a detailed set of patient outcomes over a long time, and time-varying effects of a group of variables. The results presented advance our understanding of the long-term prognostic characteristics in colorectal cancer and are expected to inspire future studies and clinical care strategies.Keywords
Funding Information
- Faculty of Medicine, Memorial University (N/A (Dean's Transition Award), N/A (Dean's Fellowship))
- TPMI/NLSUPPORT Educational Funding Award (N/A (fellowship))
- Beatrice Hunter Cancer Research Institute (N/A (the Cancer Research Training Program of the Beatrice Hunter Cancer Research Institute, with funds provided by the Terry Fox Research Institute))
This publication has 71 references indexed in Scilit:
- Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterionHPB, 2011
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerBritish Journal of Cancer, 2011
- Observational Studies: Cohort and Case-Control StudiesPlastic and Reconstructive Surgery, 2010
- The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial diseaseGut, 2010
- Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancerBMC Medical Research Methodology, 2010
- Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast CancerAmerican Journal of Epidemiology, 2009
- Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized TrialsJournal of Clinical Oncology, 2009
- Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancerBreast Cancer Research and Treatment, 2008
- Mutations of the BRAF gene in human cancerNature, 2002
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994